For patients on weekly insulin (AWIQLI), do you recommend reducing their dose prior to major surgery?

Thanks for the question.

AWIQLI (insulin icodec) has a half-life of 8 days. Insulin efsitora, which has a half-life of 19 days, was just approved. Both are approved only for people with type 2 diabetes. These weekly basal insulins have the potential to improve compliance and reduce the burden of inj...